Patents/Assignees

THERAVANCE BIOPHARMA R&D IP, LLC

37 patents in portfolio

US11718591utility2023
Crystalline (2s,4r)-5-(5′-chloro-2′-fluoro-[1,1′-biphenyl]-4-yl)-2-(ethoxymethyl)-4-(3-hydroxyisoxazole-5-carboxamido)-2- Methylpentanoic Acid and Uses Thereof
0 cites
US11718616utility2023
JAK Kinase Inhibitor Compounds for Treatment of Respiratory Disease
0 cites
US11713315utility2023
5 to 7 Membered Heterocyclic Amides as JAK Inhibitors
0 cites
US11702415utility2023
Crystalline Hydrate of a JAK Inhibitor Compound
0 cites
US11697648utility2023
Fused Pyrimidine Pyridinone Compounds as JAK Inhibitors
0 cites
US11691948utility2023
Crystalline Freebase Forms of a Biphenyl Compound
0 cites
US11673879utility2023
Substituted Pyrimidines and Methods of Use
0 cites
US11667637utility2023
Fused Imidazo-piperidine JAK Inhibitors
0 cites
US11649209utility2023
Crystalline Freebase Forms of a Biphenyl Compound
0 cites
US11642332utility2023
(2r,4r)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole-2-carbonyl)amino]pentanoic Acid
0 cites
US11634413utility2023
Neprilysin Inhibitors
0 cites
US11634419utility2023
Dimethyl Amino Azetidine Amides as JAK Inhibitors
0 cites
US11608354utility2023
Prodrugs of a JAK Inhibitor Compound for Treatment of Gastrointestinal Inflammatory Disease
0 cites
US11596624utility2023
Crystalline Form of a 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine Compound
0 cites
US11590116utility2023
Substituted Pyridines and Methods of Use
0 cites
US11547687utility2023
Neprilysin Inhibitors
0 cites
US11548887utility2023
8-azabicyclo[3.2.1]octane Compounds as Mu Opioid Receptor Antagonists
0 cites

← PreviousPage 2 of 2